Bringing DC healthcare providers the latest news, events, and resources to improve care for patients with substance use disorders and chronic pain management.
November 2023
Education Opportunities
Details coming soon!
DACS Webinar
Treatment for Opioid Use Disorder in Carceral Settings: Background, Implementation, Risk Mitigation, Acceptance
Presented by DACS Medical Director, Eric Weintraub, MD
BMC Grayken Center for Addiction TTA
Outpatient Management of Alcohol Withdrawal Syndrome
D.C. seats opioid commission as overdose deaths rise
Dr. Edwin Chapman, addiction medicine physician, was appointed to DC's new Opioid Abatement Advisory Commission. The board will recommend how to spend settlement money to slow an epidemic with an outsize impact on older Black men that is increasingly claiming young lives.
Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
A cohort study on 91,914 Medicaid enrollees in 2020 indicates that initiating buprenorphine treatment via telemedicine enhances retention without altering odds of opioid-related nonfatal overdose, highlighting telemedicine's potential during buprenorphine initiation.
Guidance offered for treating patients exposed to xylazine
"The animal sedative is now commonly found in illegally manufactured fentanyl and may pose even greater risks than that drug, according to authors of a recent review."
Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries
Only 6.1% of Medicare disability beneficiaries with opioid use disorder received buprenorphine within six months of diagnosis according to a recent study, while Black beneficiaries were half as likely as white beneficiaries to receive timely buprenorphine treatment.
Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study
